Form 4: Incyte EVP & General Counsel Receives Equity Awards

Incyte Corporation's EVP & General Counsel, Richard A. Hoffman, was granted restricted stock units, stock options, and performance shares effective December 1, 2025.

Summary

• Richard A. Hoffman, EVP & General Counsel, received an award of 9,466 restricted stock units (RSUs) on December 1, 2025. These RSUs will vest 25% annually over four years and convert to common stock on a one-for-one basis.
• Hoffman was also granted 43,301 employee stock options on December 1, 2025, with an exercise price of $102.04 and an expiration date of December 1, 2035. These options will become exercisable in 37 installments, with 25% vesting after one year and the remainder vesting monthly over three years.
• Additionally, 23,665 performance shares were awarded on December 1, 2025. Each performance share can yield up to 200% of one common share, based on Incyte's relative total shareholder return (TSR) against a fixed peer group over a three-year performance period starting January 1, 2025. These shares vest on December 1, 2028, contingent on continued service.

Sentiment

Score: 7

Explanation: The filing indicates a standard executive equity grant, which is generally positive for aligning management incentives with shareholder interests, but it's a routine disclosure rather than a significant operational or financial announcement.

Positives

• Grant of 9,466 restricted stock units (RSUs) to a key executive, aligning interests with shareholders.
• Award of 43,301 employee stock options, providing long-term incentive for executive performance.
• Grant of 23,665 performance shares tied to the company's relative Total Shareholder Return (TSR) over a three-year period, promoting performance-based compensation.

Future Outlook

The grants include long-term incentives designed to align executive interests with shareholder value creation over multi-year periods. RSUs vest over four years, stock options vest over approximately four years, and performance shares are tied to a three-year TSR performance period ending December 1, 2028.

Industry Context

This filing reports an individual executive's equity compensation, which is a standard practice across industries to incentivize and retain senior management. It does not provide broader industry-specific context or trends.

Stakeholder Impact

• Shareholders: Potential long-term alignment of executive interests with shareholder value through performance-based equity. Potential for future dilution upon vesting/exercise, though this is standard for equity compensation.
• Employees: Reflects standard executive compensation practices, potentially influencing broader employee incentive programs.

Next Steps

• Vesting of 25% of RSUs annually over four years from December 1, 2025.
• Vesting of 25% of stock options after one year from December 1, 2025, with the remainder vesting monthly over three years.
• Evaluation of Incyte's relative Total Shareholder Return (TSR) over the three-year performance period starting January 1, 2025, for performance share earning.
• Vesting of earned performance shares on December 1, 2028, subject to continued service.

Key Dates

Recommendation

This Form 4 filing details a routine equity grant to a senior executive, which is a standard component of executive compensation designed to align management incentives with long-term shareholder value. It does not contain new operational, financial, or strategic information that would warrant a change in investment recommendation. The grants are expected and do not alter the fundamental outlook for the company, thus a 'hold' recommendation remains appropriate based solely on this filing.

Keywords

Incyte, INCY, Form 4, Restricted Stock Units, RSUs, Stock Options, Performance Shares, Executive Compensation, Equity Grant, Richard A. Hoffman, EVP & General Counsel